Fundraise / allotmentFiled on NSE ·
United Heat Transfer Limited approves half-year financial results for Sept 2026
United Heat Transfer · Industrial Products
Key highlights
- Board meeting held on 13 Nov 2026 approved unaudited financial results for half-year ended 30 Sept 2026
- Audit Committee reviewed results; limited review by statutory auditors completed with no material misstatement
- Preferential allotment of 29,68,000 equity shares approved post half-year end by Board on 12 Oct 2026
Original filing
Outcome of Board Meeting
Read the filing on NSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Rossell Techsys
Aerospace & Defense
Revenue growth 40%+Margin up 2%+
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Other fundraise / allotment filings this fortnight
- Fundraise / allotmentJubilant PharmovaJubilant Pharmova reports Q2 and H1 FY27 financial results and operational updates
- Fundraise / allotmentNatural CapsulesNatural Capsules Limited approves Q2 2026 results and preferential allotment
- Fundraise / allotmentNatural CapsulesNatural Capsules Ltd announces Q2 FY27 results and approves preferential allotment
- Fundraise / allotmentDestiny Logistics & InfraDestiny Logistics & Infra Ltd announces key resignations, appointments, and warrant lapse
- Fundraise / allotmentShalimar PaintsShalimar Paints Limited announces QIP Committee approval for equity shares issue
- Fundraise / allotmentOrchid PharmaOrchid Pharma Limited QIP proceeds utilization and monitoring report for Q2 FY 2026-27
Potential multibaggers · Q2 FY27
Potential multibaggers in Industrial Products
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.